Literature DB >> 7377640

Compliance differences following administration of theophylline at six- and twelve-hour intervals.

D G Tinkelman, G E Vanderpool, M S Carroll, E G Page, D L Spangler.   

Abstract

This study evaluated the compliance differences between administration of theophylline at six- and 12-hour intervals in a pediatric outpatient population. Compliance was statistically better with the sustained release tablets than with the short acting tablets.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7377640

Source DB:  PubMed          Journal:  Ann Allergy        ISSN: 0003-4738


  6 in total

Review 1.  Assessing medication adherence in the elderly: which tools to use in clinical practice?

Authors:  Eric J MacLaughlin; Cynthia L Raehl; Angela K Treadway; Teresa L Sterling; Dennis P Zoller; Chester A Bond
Journal:  Drugs Aging       Date:  2005       Impact factor: 3.923

2.  The effect of dosing time on the pharmacokinetics and pharmacodynamics of a 'once-a-day' sustained release theophylline preparation.

Authors:  H Lamont; R Pauwels; M Van der Straeten
Journal:  Br J Clin Pharmacol       Date:  1987-12       Impact factor: 4.335

3.  Can compliance in children be improved?

Authors:  J Baird-Lambert
Journal:  Indian J Pediatr       Date:  1986 Mar-Apr       Impact factor: 1.967

Review 4.  Interventions for enhancing medication adherence.

Authors:  Robby Nieuwlaat; Nancy Wilczynski; Tamara Navarro; Nicholas Hobson; Rebecca Jeffery; Arun Keepanasseril; Thomas Agoritsas; Niraj Mistry; Alfonso Iorio; Susan Jack; Bhairavi Sivaramalingam; Emma Iserman; Reem A Mustafa; Dawn Jedraszewski; Chris Cotoi; R Brian Haynes
Journal:  Cochrane Database Syst Rev       Date:  2014-11-20

Review 5.  A clinical and pharmacokinetic basis for the selection and use of slow release theophylline products.

Authors:  L Hendeles; R P Iafrate; M Weinberger
Journal:  Clin Pharmacokinet       Date:  1984 Mar-Apr       Impact factor: 6.447

6.  Some socioeconomic factors in the selection of blood pressure drugs in New Orleans, Louisiana.

Authors:  F G McMahon; A Johnson; W Duncan
Journal:  Cardiovasc Drugs Ther       Date:  1989-10       Impact factor: 3.727

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.